• 12102 Citations

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Interests

Colon cancer, Esophagus cancer, Gastric cancer, Hepatocellular cancer, Pancreas cancer, Rectal cancer

Certifications and Licenses

Medical Oncology

Training Experience

1996Residency, Boston University Medical Center
2000Fellowship, Northwestern University, McGaw Medical Center (Northwestern Memorial Hospital)

Education/Academic qualification

MD, University Of California-San Diego

… → 1993

Research interests

  • Anal Cancer
  • Colon/Rectal Cancer
  • GI Stromal Tumors
  • Gastrointestinal Malignancies
  • Liver Cancer
  • Pancreatic Cancer
  • Stomach Cancer

Fingerprint Dive into the research topics where Mary Frances Mulcahy is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 27 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.


Research Output

Correction to: Prognosticating Survival in Hepatocellular Carcinoma with Elevated Baseline Alpha-fetoprotein Treated with Radioembolization Using a Novel Laboratory Scoring System: Initial Development and Validation (CardioVascular and Interventional Radiology, (2019), 42, 5, (700-711), 10.1007/s00270-019-02191-z)

Ali, R., Yang, Y., Antkowiak, M., Gabr, A., Mora, R., Abouchaleh, N., Asadi, A. A., Kulik, L., Ganger, D., Abecassis, M., Katariya, N., Mulcahy, M., Benson, A., Mahalingam, D., Thornburg, B., Mouli, S., Lewandowski, R. J., Salem, R. & Riaz, A., Jan 1 2020, (Accepted/In press) In : Cardiovascular and Interventional Radiology.

Research output: Contribution to journalComment/debate

Open Access
  • Failure to administer recommended chemotherapy: Acceptable variation or cancer care quality blind spot?

    Ellis, R. J., Schlick, C. J. R., Feinglass, J., Mulcahy, M. F., Benson, A. B., Kircher, S. M., Yang, T. D., Odell, D. D., Bilimoria, K. & Merkow, R. P., Feb 1 2020, In : BMJ Quality and Safety. 29, 2, p. 103-112 10 p.

    Research output: Contribution to journalArticle

  • 1 Scopus citations

    Phase II Study of Preoperative Chemoradiotherapy with Oxaliplatin, Infusional 5-Fluorouracil, and Cetuximab Followed by Postoperative Docetaxel and Cetuximab in Patients with Adenocarcinoma of the Esophagus: A Trial of the ECOG-ACRIN Cancer Research Group (E2205)

    Gibson, M. K., Catalano, P., Kleinberg, L. R., Staley, C. A., Montgomery, E. A., Jimeno, A., Song, W., Mulcahy, M. F., Leichman, L. P. & Benson, A. B., Jan 1 2020, In : Oncologist. 25, 1, p. e53-e59

    Research output: Contribution to journalArticle

  • Docetaxel, Oxaliplatin, and 5-Fluorouracil (DOF) in Metastatic and Unresectable Gastric/Gastroesophageal Junction Adenocarcinoma: A Phase II Study with Long-Term Follow-Up

    Rosenberg, A. J., Rademaker, A., Hochster, H. S., Ryan, T., Hensing, T., Shankaran, V., Baddi, L., Mahalingam, D., Mulcahy, M. F. & Benson, A. B., Jan 1 2019, In : Oncologist. 24, 8, p. 1039-e642

    Research output: Contribution to journalArticle

  • Esophageal and esophagogastric junction cancers, Version 2.2019

    Ajani, J. A., D'Amico, T. A., Bentrem, D. J., Chao, J., Corvera, C., Das, P., Denlinger, C. S., Enzinger, P. C., Fanta, P., Farjah, F., Gerdes, H., Gibson, M., Glasgow, R. E., Hayman, J. A., Hochwald, S., Hofstetter, W. L., Ilson, D. H., Jaroszewski, D., Johung, K. L., Keswani, R. N. & 18 others, Kleinberg, L. R., Leong, S., Ly, Q. P., Matkowskyj, K. A., McNamara, M., Mulcahy, M. F., Paluri, R. K., Park, H., Perry, K. A., Pimiento, J., Poultsides, G. A., Roses, R., Strong, V. E., Wiesner, G., Willett, C. G., Wright, C. D., McMillian, N. R. & Pluchino, L. A., Jan 1 2019, In : JNCCN Journal of the National Comprehensive Cancer Network. 17, 7, p. 855-883 29 p.

    Research output: Contribution to journalArticle

    Open Access
  • 11 Scopus citations